Drug Markets/Adalimumab-Aaty

Adalimumab-Aaty

2 NDCs across 1 manufacturer|1 Generic,1 Brand

Adalimumab-Aaty is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $31 million on Adalimumab-Aaty across 3,688 claims for 692 beneficiaries.

Adalimumab-Aaty is available as 2 NDCs from 1 manufacturer (1 generic, 1 brand), with NADAC prices from $492.14 to $913.60 per EAa 86% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

1G / 1B

Manufacturers

1

competing in market

Price Spread

$492.14 – $913.60

per EA

7d Activity

11 flat

avg -0.4% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing ADALIMUMAB-AATY

Drug Portfolio

2 NDCs total, 2 shown

Drug Price 7d Change
YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR
$913.5967
per EA
ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR
$492.1422
per EA
-0.41%

Frequently Asked Questions

What is Adalimumab-Aaty used to treat?

Adalimumab-Aaty is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Adalimumab-Aaty?

In 2024, Medicare Part D spent $31 million on Adalimumab-Aaty across 3,688 claims for 692 beneficiaries.

How many Adalimumab-Aaty products are on the market?

The Adalimumab-Aaty drug market contains 2 NDCs from 1 manufacturer — 1 generic and 1 brand product.

What is the price range for Adalimumab-Aaty?

NADAC reference prices for Adalimumab-Aaty range from $492.1422 to $913.5967 per EA — a 86% difference between cheapest and most expensive.

Is generic Adalimumab-Aaty cheaper than brand?

The average generic NADAC for Adalimumab-Aaty is $492.1422 per EA, versus $913.5967 for brand-labeled products — generic is about 46% cheaper on average.

Which manufacturers make Adalimumab-Aaty?

1 manufacturer lists Adalimumab-Aaty in NADAC. Ranked by number of NDCs, the largest are CELLTRION USA, Inc. (2).

How has the price of Adalimumab-Aaty changed recently?

Over the past 7 days, 0 Adalimumab-Aaty NDCs rose and 1 fell, with a market-wide average change of -0.4%.